NovaBay Non Currrent Assets Other from 2010 to 2025

NBY Stock  USD 0.61  0.01  1.61%   
NovaBay Pharmaceuticals Non Currrent Assets Other yearly trend continues to be fairly stable with very little volatility. Non Currrent Assets Other will likely drop to about 300 K in 2025. Non Currrent Assets Other is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. View All Fundamentals
 
Non Currrent Assets Other  
First Reported
2009-12-31
Previous Quarter
(1.00)
Current Value
495 K
Quarterly Volatility
216.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NovaBay Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 229.5 K, Interest Expense of 4.6 M or Other Operating Expenses of 16.9 M, as well as many indicators such as Price To Sales Ratio of 0.0638, Dividend Yield of 0.0 or PTB Ratio of 0.28. NovaBay financial statements analysis is a perfect complement when working with NovaBay Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NovaBay Pharmaceuticals Correlation against competitors.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.

Latest NovaBay Pharmaceuticals' Non Currrent Assets Other Growth Pattern

Below is the plot of the Non Currrent Assets Other of NovaBay Pharmaceuticals over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. NovaBay Pharmaceuticals' Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NovaBay Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Non Currrent Assets Other10 Years Trend
Slightly volatile
   Non Currrent Assets Other   
       Timeline  

NovaBay Non Currrent Assets Other Regression Statistics

Arithmetic Mean299,285
Geometric Mean181,584
Coefficient Of Variation71.89
Mean Deviation195,910
Median300,006
Standard Deviation215,153
Sample Variance46.3B
Range611K
R-Value0.59
Mean Square Error32.1B
R-Squared0.35
Significance0.02
Slope26,843
Total Sum of Squares694.4B

NovaBay Non Currrent Assets Other History

2025300 K
2024571.5 K
2023497 K
2022489 K
2020476 K
2019 2000.0
201877 K

About NovaBay Pharmaceuticals Financial Statements

NovaBay Pharmaceuticals investors use historical fundamental indicators, such as NovaBay Pharmaceuticals' Non Currrent Assets Other, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NovaBay Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Currrent Assets Other571.5 K300 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NovaBay Stock Analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.